Veurit was an overall app developed by Sound Vaccine. It was removed from Google Play Aug 7, 2025 and is no longer available for download.
Download Statistics
User Ratings
The app had no ratings.
App Information
Veurit was free to download. The APK download size was 32.30 MB. The last available version was 1.0.4. The last update was on March 4, 2025.
Technical Requirements
The app had a content rating of Everyone. The app had been available on Google Play March 2024.
Description
We provide operation functions so that users can freely choose. Enjoy more convenient eye massage with the dedicated app. You can remotely control your device and provide content you can enjoy in the app. Please use the app with your device. * Before using the device, be sure to consult with a specialist if you have a disease or are concerned about side effects.
CLINICALLY PROVEN Using Threshold Sound ConditioningTM technology (TSC), our sound therapy stimulates the inner ear cells to target damaged hearing for each ear. TSC technology had been clinically proven with:
Stanford Univ. Samsung Medical Center Palo Alto Medical Foundation Nanjing Univ. Chung Ang Univ.
DISCLAIMER VEURIT isn’t a clinical hearing test. This should be considered a hearing check or screening and cannot be used to prescribe a hearing aid. It should only be used as a method to see if you may have hearing loss since it is not a clinical hearing test. This isn’t a medical device and hasn’t been reviewed by the FDA as a hearing loss solution. It’s not intended to self-diagnose any disease, injury or disability like tinnitus or hearing loss. If you believe you have hearing loss or tinnitus, please consult your doctor, or other qualified healthcare professional before using this app. Use this app at your own risk. VEURITTM does not take responsibility for direct or indirect damage that could result from its use.
Each subscription will automatically renew 3 days before the expiration date for
the same time period. Subscriptions can be cancelled at any time before the renewal.